Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis

American Journal of Surgical Pathology

Volumn 37, Issue 8, 2013, Pages 1173-1181

  Karai, Laszlo J ^a,b   Kadin, Marshall E ^c   Hsi, Eric D ^d   Sluzevich, Jason C ^e   Ketterling, Rhett P ^f   Knudson, Ryan A ^f   Feldman, Andrew L ^f  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Cockerell and Associates ^*  (United States)

^c ROGER WILLIAMS MEDICAL CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e MAYO CLINIC   (United States)

^f MAYO CLINIC   (United States)

Author keywords

chromosomal translocation; cutaneous CD30 positive T cell lymphoproliferative disorder; DUSP22; fluorescence in situ hybridization; genetics; lymphomatoid papulosis; T cell lymphoma

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE; DUSP22 PROTEIN, HUMAN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 4; INTERFERON REGULATORY FACTOR-4; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE; TUMOR MARKER;

AGED; ARTICLE; BIOPSY; CHROMOSOME 6; CLASSIFICATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOMATOID PAPULOSIS; MALE; PATHOLOGY; PHENOTYPE; PREDICTIVE VALUE; PROGNOSIS; SKIN TUMOR; T LYMPHOCYTE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOPSY; CHROMOSOMES, HUMAN, PAIR 6; DUAL-SPECIFICITY PHOSPHATASES; FEMALE; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERFERON REGULATORY FACTORS; LYMPHOMATOID PAPULOSIS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASES; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SKIN NEOPLASMS; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL;

EID: 84880570203     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318282d01e     Document Type: Article

References (32)

1. Macaulay WL. Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign-histologically malignant. Arch Dermatol. 1968;97:23-30
2. Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: A report from the Dutch Cutaneous Lymphoma Group on the longterm follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000;95:3653-3661
3. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785
4. Swerdlow S, Campo E, Harris N, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008
5. El Shabrawi-Caelen L, Kerl H, Cerroni L. Lymphomatoid papulosis: Reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol. 2004;140: 441-447
6. Saggini A, Gulia A, Argenyi Z, et al. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases. Am J Surg Pathol. 2010;34:1168-1175
7. Magro CM, Crowson AN, Morrison C, et al. CD8+ lymphomatoid papulosis and its differential diagnosis. Am J Clin Pathol. 2006;125:490-501
8. Kempf W, Kazakov DV, Scharer L, et al. Angioinvasive lymphomatoid papulosis: A new variant simulating aggressive lymphomas. Am J Surg Pathol. 2013;37:1-13
9. Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol. 1993;28:973-980
10. Feldman AL, Law M, Remstein ED, et al. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia. 2009;23:574-580
11. Pham-Ledard A, Prochazkova-Carlotti M, Laharanne E, et al. IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: A study of 54 cases. J Invest Dermatol. 2010;130:816-825
12. Wada DA, Law ME, Hsi ED, et al. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: A multicenter study of 204 skin biopsies. Mod Pathol. 2011;24: 596-605
13. Patnaik MM, Knudson RA, Gangat N, et al. Chromosome 9p24 abnormalities: Prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates. Eur J Haematol. 2010;84:518-524
14. Feldman AL, Dogan A, Smith DI, et al. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood. 2011;117:915-919
15. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALKpositive lymphoma: A single disease with a broad spectrum of morphology. Blood. 1998;91:2076-2084
16. Hsu YJ, Su LH, Hsu YL, et al. Localized lymphomatoid papulosis. J Am Acad Dermatol. 2010;62:353-356
17. Kadin M, Nasu K, Sako D, et al. Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens. Am J Pathol. 1985;119:315-325
18. Berti E, Cerri A, Cavicchini S, et al. Primary cutaneous gamma/ delta T-cell lymphoma presenting as disseminated pagetoid reticulosis. J Invest Dermatol. 1991;96:718-723
19. Haghighi B, Smoller BR, LeBoit PE, et al. Pagetoid reticulosis (Woringer-Kolopp disease): An immunophenotypic, molecular, and clinicopathologic study. Mod Pathol. 2000;13:502-510
20. Steffen C. Ketron-Goodman disease, Woringer-Kolopp disease, and pagetoid reticulosis. Am J Dermatopathol. 2005;27:68-85
21. Berti E, Tomasini D, Vermeer MH, et al. Primary cutaneous CD8- positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol. 1999;155:483-492
22. Heald P, Subtil A, Breneman D, et al. Persistent agmination of lymphomatoid papulosis: An equivalent of limited plaque mycosis fungoides type of cutaneous T-cell lymphoma. J Am Acad Dermatol. 2007;57:1005-1011
23. Cerroni L, Rieger E, Hodl S, et al. Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma. Am J Surg Pathol. 1992;16: 543-552
24. Horwitz SM, Duvic M, Hsi ED. Clinical roundtable monograph. The management of aggressive T-cell lymphoma: A discussion on transformed mycosis fungoides. Clin Adv Hematol Oncol. 2010;8: 1-15
25. Benner MF, Jansen PM, Vermeer MH, et al. Prognostic factors in transformed mycosis fungoides: A retrospective analysis of 100 cases. Blood. 2012;119:1643-1649
26. Laharanne E, Oumouhou N, Bonnet F, et al. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes. J Invest Dermatol. 2010;130:1707-1718
27. Grubb B, Henderson DB, Pandya AG. Adult T-cell lymphoma/ leukemia presenting as pagetoid reticulosis of the palms and soles. J Am Acad Dermatol. 2011;65:1063-1064
28. Toro JR, Liewehr DJ, Pabby N, et al. Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood. 2003;101:3407-3412
29. Evans HL, Winkelmann RK, Banks PM. Differential diagnosis of malignant and benign cutaneous lymphoid infiltrates: A study of 57 cases in which malignant lymphoma had been diagnosed or suspected in the skin. Cancer. 1979;44:699-717
30. Oliver GF, Winkelmann RK. Unilesional mycosis fungoides: A distinct entity. J Am Acad Dermatol. 1989;20:63-70
31. Beljaards RC, Willemze R. The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Br J Dermatol. 1992;126:596-602
32. Alonso A, Merlo JJ, Na S, et al. Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR). J Biol Chem. 2002; 277:5524-5528